Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Compound indigo, also known as 复方青黛胶囊, is a traditional Chinese herbal medicine indicated for the treatment of inflammatory skin conditions such as psoriasis, pityriasis rosea, and drug eruption. It functions by clearing heat, detoxifying, resolving blood stasis, and relieving itching. Its mechanism of action involves inhibiting epidermal cell proliferation, promoting granular cell growth, regulating immune responses by lowering IL-2 and IL-8 levels, and improving blood rheology. Key active components derived from Indigo Naturalis, such as indigo, indirubin, and tryptanthrin, contribute to its anti-proliferative, anti-inflammatory, and anti-angiogenic effects through modulation of various signaling pathways including TAK1, JAK3/STAT3, Wnt/β-catenin, Akt/PKB, FAK, and AP-1/c-Jun.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on compound indigo.